Shandong Xinhua Pharmaceutical Company Limited (00719) said its net profit attributable to shareholders of listed company was RMB147.47 million for the six months ended 30 June 2019, a year-on-year increase of 19.54%. The earnings per share were RMB0.24. No dividend will be distributed.
The operating income was RMB3.1 billion, a year-on-year increase of 15.34%.
全新節目《說說心理話》青少年不可以戀愛！？真實個案講述驚心動魄經歷► 即睇
